MetaTrader
  • Marchés
  • Graphique & Idées
  • Algo
  • Nouvelles
  • Store
  • Courtiers
  • Télécharger
  • Calendrier Economique
  • Signaux de trading
  • Terminal Web
  • English English
  • Русский Русский
  • 中文 中文
  • Español Español
  • Português Português
  • 日本語 日本語
  • 한국어 한국어
  • Français Français
  • Italiano Italiano
  • Türkçe Türkçe
Legend Biotech Corporation American Depositary Shares

LEGN

#6989
Legend Biotech Corporation American Depositary Shares
19.0000
-0.39%
Secteur:
Base:
Devise de Profit:
Range quotidien
18.9900
19.0000
Range Annuel
16.2500
33.4800
Changement quotidien
-0.39%
Changement Mensuel
+4.17%
Evolution sur 6 mois
-40.59%
Changement Annuel
-40.59%
Clôture Précédente
19.0750
Open
18.9900
Bid
Ask
Low
18.9900
High
19.0000
Volume
131
  1. Marchés
  2. Actions des Marchés US
  3. Soins de Santé
  4. LEGN
Open full chart

Financials

Overview Relevé Statistics Dividends
Quarterly Annual
Value Q4, 24 TTM

Nouvelles

Investor's Business Daily Investor's Business Daily
MSFT VZ MRK AMGN JNJ
vorgestern, 21:30
These Stocks Lead Dow Jones In February. Hint: It's Not AI Companies.
Seeking Alpha Seeking Alpha
GILD JNJ LEGN
2026.02.23
What Gilead Is Getting Through The Acquisition Of Arcellx
Investing Investing
C JPM-PL LLY ORCL EXPE
2026.02.23
American Express, Oracle among market cap stock movers on Monday
Investing Investing
GILD LEGN ACLX
2026.02.23
Raymond James bekräftigt Rating für Legend Biotech wegen erheblicher Bewertungs­lücke
Investing Investing
LEGN
2026.02.23
Raymond James reiterates Legend Biotech stock rating on valuation gap
Investor's Business Daily Investor's Business Daily
GILD ACLX JNJ LEGN
2026.02.23
Gilead Bets Big On New Drug With $7.8 Billion Deal As It Takes On J&J
Investing Investing
AIRG LEGN
2026.02.19
Germany stocks lower at close of trade; DAX down 1.03%
Investing Investing
LEGN
2026.02.18
Germany stocks higher at close of trade; DAX up 1.16%
Investing Investing
LEGN
2026.02.17
AKTIEN IM FOKUS: Immobilienwerte gefragt - Aroundtown ragt nach Bericht heraus
Investing Investing
LEGN
2026.02.12
Wettbewerbssorgen: Rothschild Redburn stuft Legend-Biotech-Aktie ab
Investing Investing
LEGN
2026.02.12
Legend Biotech stock rating downgraded by Rothschild Redburn on competition concerns
Seeking Alpha Seeking Alpha
RVMD ABBV FIX FTAI ABVX
2026.01.30
Harbor Small Cap Growth Fund Q4 2025 Portfolio Performance

Marchés

  • Actions
  • Devises
  • Crypto-monnaies
  • Métaux
  • Matières premières

Graphique & Idées

  • Idées de Trading
  • Idées de Formations
  • Graphiques

MQL5 Community

  • Marché
  • Signaux
  • Forum
  • Articles
  • CodeBase

Nouvelles

  • Actions
  • Devises
  • Crypto-monnaies
  • Métaux
  • Matières premières

Courtiers

  • Tous les Courtiers
  • Forex
  • Actions
  • Métaux
MetaTrader 5
MQL5 Channels
Economic Calendar
Clause de Non-Responsabilité et Divulgation des Risques Conditions d'Utilisation Contacts et Demandes Légal
Copyright 2000-2026, MetaQuotes Ltd